Self-Administered Lidocaine Gel for Pain Management With IUD Insertion
Status:
Completed
Trial end date:
2017-10-19
Target enrollment:
Participant gender:
Summary
For intrauterine device (IUD) insertion, currently there are no standardized clinical
guidelines for pain management. The investigators aim to explore whether adequate pain relief
is possible through self-administered, non-invasive means alone. Reducing pain associated
with IUD insertion may benefit patients and providers. When patients are comfortable during
their procedure, it is likely the provider can more quickly and with fewer complications
perform the insertion. The investigators propose to explore the effect of a locally applied
vaginal lidocaine gel in place of the standard of care pain management, no intervention,
prior to IUD insertions. This is a superiority, blinded, randomized controlled trial.